Young S Lee

3PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 08, 2025
T-Cell Receptor and Immune Gene Expression Pharmacodynamics for Durvalumab Alone and with Tremelimumab or Bevacizumab in Unresectable Hepatocellular Carcinoma.

Robin K Kelley, Young Lee, James Conway

|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree, Emma Titmuss, James T Topham

|Aug 25, 2022
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer.

James T Topham, Chris J O'Callaghan, Harriet Feilotter

Pageof 1

Frequent Collaborators

2 joint publications

Hagen F Kennecke

2 joint publications

Kimberly C Banks

2 joint publications

Dongsheng Tu

2 joint publications

Eric X Chen